Small cell lung cancer (SCLC) is a subtype of lung cancer with neuroendocrine characteristics, It is more aggressive, and prone to distant metastasis and resistant to platinum-based drugs, then the pr
We exploited six paired pre-treatment and post-chemotherapy circulating tumour cell patient-derived explant (CDX) models from donors with extensive stage SCLC to investigate changes at disease progres
We analyzed a prospective cohort of 49 plasma samples obtained before, during, and after treatment from 20 patients with recurrent small cell lung cancer. We conducted cfDNA low-pass whole genome sequ